Keros Therapeutics Inc (KROS) — Free Cash Flow Generation Index

Latest as of September 2025: 0.96x

Keros Therapeutics Inc (KROS) has a Free Cash Flow Generation Index of 0.96x as of September 2025. Free cash flow of $3.12 Million represents 1% of operating cash flow ($3.25 Million). Read Keros Therapeutics Inc total liabilities for a breakdown of total debt and financial obligations.

FCF Generation Index

0.96x
Free Cash Flow / Operating CF

Free Cash Flow

$3.12 Million
USD

Operating Cash Flow

$3.25 Million
USD

Capital Expenditures

$132.00K
USD

Keros Therapeutics Inc Free Cash Flow Generation Index (2018–2018)

Historical FCF Generation Index trend for Keros Therapeutics Inc across 1 annual periods. Explore reinvestment intensity of Keros Therapeutics Inc to see what proportion of operating cash flow is directed to capital expenditures.

Annual Free Cash Flow Generation for Keros Therapeutics Inc (2018–2018)

Year-by-year Free Cash Flow Generation Index for Keros Therapeutics Inc. For the full company profile including market capitalisation, see how much is Keros Therapeutics Inc worth.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2018 0.97x $6.83 Million $7.04 Million $217.00K
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).